Search research articles
Contact Us
Filters
Showing results (191-200 of 236) with videos related to
Page
of 24
Sort By:
Blood
|
January 30, 2010
G-CSF-induced aneuploidy does not affect CD34+ cells and does not require cell division
Caroline Marmier-Savet, Fabrice Larosa, Faezeh Legrand, et al.
Blood
|
October 29, 2008
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years
Emmanuel Gyan, Charles Foussard, Philippe Bertrand, et al.
Haematologica
|
March 12, 2010
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group
Rémy Gressin, Sylvie Caulet-Maugendre, Eric Deconinck, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 27, 2018
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation
Simone Cesaro, Gloria Tridello, Nicole Blijlevens, et al.
Haematologica
|
November 9, 2014
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot-Delettre, Anne Roggy, Arthur E Frankel, et al.
Blood
|
September 25, 2004
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells
Francine Garnache-Ottou, Laurence Chaperot, Sabeha Biichle, et al.
Bone Marrow Transplantation
|
December 19, 2020
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study
David Beauvais, Elodie Drumez, Didier Blaise, et al.
Blood
|
February 3, 2005
High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS
Eric Deconinck, Charles Foussard, Noel Milpied, et al.
Journal of Hematology & Oncology
|
July 5, 2020
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
Eolia Brissot, Myriam Labopin, Ian Moiseev, et al.
Journal for Immunotherapy of Cancer
|
July 8, 2022
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia
Rim Trad, Walid Warda, Vincent Alcazer, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 236) with videos related to
Sort By:
Page
of 24
Blood
|
January 30, 2010
G-CSF-induced aneuploidy does not affect CD34+ cells and does not require cell division
Caroline Marmier-Savet, Fabrice Larosa, Faezeh Legrand, et al.
Blood
|
October 29, 2008
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years
Emmanuel Gyan, Charles Foussard, Philippe Bertrand, et al.
Haematologica
|
March 12, 2010
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group
Rémy Gressin, Sylvie Caulet-Maugendre, Eric Deconinck, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 27, 2018
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation
Simone Cesaro, Gloria Tridello, Nicole Blijlevens, et al.
Haematologica
|
November 9, 2014
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot-Delettre, Anne Roggy, Arthur E Frankel, et al.
Blood
|
September 25, 2004
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells
Francine Garnache-Ottou, Laurence Chaperot, Sabeha Biichle, et al.
Bone Marrow Transplantation
|
December 19, 2020
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study
David Beauvais, Elodie Drumez, Didier Blaise, et al.
Blood
|
February 3, 2005
High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS
Eric Deconinck, Charles Foussard, Noel Milpied, et al.
Journal of Hematology & Oncology
|
July 5, 2020
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
Eolia Brissot, Myriam Labopin, Ian Moiseev, et al.
Journal for Immunotherapy of Cancer
|
July 8, 2022
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia
Rim Trad, Walid Warda, Vincent Alcazer, et al.
Page
of 24